Some studies have evidenced that these algorithms not only diminish interobserver variability but can also prognosticate the treatment response to immunotherapy by assessing programmed death ligand 1 (PD-L1) expression or tumor infiltrating lymphocytes [13, 14, 16, 17]. This evidence concerns the gene CD274 and neoplasm.